- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03744897
Effect of Hypnosis Combined to Transcranial Direct Stimulation in Pain
November 22, 2018 updated by: Wolnei Caumo, Hospital de Clinicas de Porto Alegre
Effect of Hypnosis Combined to Transcranial Direct Stimulation in Cortical Activity and Pain Perception in Healthy Females
Pain is a public health condition, which causes great functional disability.
Its consequences pervade the personal and social life of the patient, leading to significant changes in their interpersonal relationships, including work, family and social spheres, reducing the ability to perform daily activities.
Conventional treatment modalities have been show a very poor therapeutic response, in that most individuals end up becoming polymedicated patients and refractory to treatment.
Among non-pharmacological techniques with promising analgesic effects it includes both the hypnotic analgesia and the transcranial stimulation of direct current (tDCS).
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Introduction: Pain is a public health condition, which causes great functional disability.
Its consequences pervade the personal and social life of the patient, leading to significant changes in their interpersonal relationships, including work, family and social spheres, reducing the ability to perform daily activities.
Conventional treatment modalities have been show a very poor therapeutic response, in that most individuals end up becoming polymedicated patients and refractory to treatment.
Among non-pharmacological techniques with promising analgesic effects it includes both the hypnotic analgesia and the transcranial stimulation of direct current (tDCS).
Objective: To evaluate the synergistic effect of hypnotic analgesia associated with tDCS under metabolites parameters and pain levels in healthy individuals before a nociceptive stimulation pattern.
Methods: it will be performed a blinded crossover sham controlled randomized clinical trial.
It will be included 32 woman healthy subjects, Susceptible to the hypnosis technique according to the Scale of Hypnotic Susceptibility (WSGC) Scale of Hypnotic Scale score.
aged 18 to 65.
They will be allocated in one of the following groups: active tDCS + hypnotic analgesia, sham tDCS + hypnotic analgesia, hypnotic analgesia and tDCS .
After a 7 days interval, the groups will be crossed in order to receive the opposite intervention of the first week.
The primary endpoints will be the electrophysiological brain parameters, such as changes in the Theta, Alpha and Gamma waves, as measured by EEG.
The secondary endpoints will be the level of pain, measured against nociceptive induced by the cold test and stimuli standardized pressure through algometry pressure and power down system modulatory pain, pain using the subject test - CPM - task.
The intra and inter-group comparisons will be made by means of two-way ANOVA followed by Bonferroni.
A p significance level of <0.05 was established.
Expected results: This study hypothesizes that a synergistic effect of analgesic techniques in pain levels in healthy subjects compared to isolated character.
Study Type
Interventional
Enrollment (Actual)
48
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Rio Grande Do Sul
-
Porto Alegre, Rio Grande Do Sul, Brazil, 90.450-120
- Hospital de Clínicas de Porto Alegre
-
Porto Alegre, Rio Grande Do Sul, Brazil, 90035-003
- Hospital de Clinicas e Porto Alegre (HCPA)
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 45 years (Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- Healthy
- Female
- 11 years of schooling
- 12 cut-off at Waterloo-Stanford Group C (WSGC)
Exclusion Criteria:
- hearing loss subjects
- formal contraindication to tDCS (pregnancy, deep brain device, epilepsy, seizure)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Hypnotic analgesia
Intervention: - Subjects will receive hypnotic analgesia |
Subjects will receive hypnotic analgesia during 20 minutes
|
|
Experimental: a-tDCS
Intervention: transcranial direct current stimulation - tDCS
|
Subjects will receive hypnotic analgesia during 20 minutes
Subjects will receive sham transcranial direct stimulation over bilateral DLPFC left/anode right/cathodal, 0mA, 20 minutes
|
|
Sham Comparator: s-tDCS
Sham comparator: transcranial direct current stimulation - tDCS
|
Subjects will receive transcranial direct stimulation over bilateral DLPFC left/anode right/cathodal, 2mA, 20 minutes
Subjects will receive hypnotic analgesia associated to transcranial direct stimulation over bilateral DLPFC left/anode right/cathodal, 2mA, 20 minutes
|
|
Experimental: Hypnotic analgesia + a-tDCS
Intervention:
|
Subjects will receive hypnotic analgesia associated to transcranial direct stimulation over bilateral DLPFC left/anode right/cathodal, 2mA, 20 minutes
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Alpha waves
Time Frame: 60 minutes
|
Variations in the alpha waves power from post to pre-intervention using electroencephalography during a cold pressor test
|
60 minutes
|
|
Change in Theta waves
Time Frame: 60 minutes
|
Variations in the theta waves power from post to pre-intervention using electroencephalography during a cold pressor test
|
60 minutes
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in beta waves
Time Frame: 60 minutes
|
Variations in the beta waves power from post to pre-intervention using electroencephalography during a cold pressor test
|
60 minutes
|
|
Change in gamma waves
Time Frame: 60 minutes
|
Variations in the gamma waves power from post to pre-intervention using electroencephalography during a cold pressor test
|
60 minutes
|
|
Change in delta waves
Time Frame: 60 minutes
|
Variations in the delta waves power from post to pre-intervention using electroencephalography during a cold pressor test
|
60 minutes
|
|
Change in Heat thermal threshold
Time Frame: 60 minutes
|
The measure will be assessed by Quantitative Sensorial Test - QST, in which a thermode delivers a heat stimulus of increasing magnitude.
Heat thermal threshold (HTT) is the averaged temperature for 3 stimuli where participant indicates the first heat sensation.
|
60 minutes
|
|
Change in Heat pain threshold
Time Frame: 60 minutes
|
The measure will be assessed by Quantitative Sensorial Test - QST, in which a thermode delivers a heat stimulus of increasing magnitude.
Heat pain threshold (HPT) is the averaged temperature for 3 stimuli where participant indicates the first heat pain sensation.
|
60 minutes
|
|
Change in Heat pain tolerance
Time Frame: 60 minutes
|
The measure will be assessed by Quantitative Sensorial Test - QST, in which a thermode delivers a heat stimulus of increasing magnitude.
Heat pain tolerance (HPTo) is the temperature for the stimulus where participant indicates the maximum pain tolerance.
|
60 minutes
|
|
Change in Numeric pain scale during CPM task
Time Frame: 60 minutes
|
The measure will be assessed by the conditioned pain modulation (CPM) task in which an ice cold water (0 a 1 degrees Celsius) is the conditioning stimulus presented to the left hand and a moderate heat pain stimulus from the QST to the contralateral hand.
The measure consists of the response using a numeric pain scale (0 - 10) for the heat pain stimulus during the CPM task.
|
60 minutes
|
|
Change in Cold Pressor Test 0 to 1 degree Celsius - time
Time Frame: 60 minutes
|
Participant puts his right hand in an ice cold water (0 a 1 degrees Celsius).
Measure consists of the time (in seconds) the participant keeps his hand in the water the maximum he could tolerance.
|
60 minutes
|
|
Change in Cold Pressor Test 10 degree Celsius - time
Time Frame: 60 minutes
|
Participant puts his right hand in an ice cold water (10 degrees Celsius).
Measure consists of the time (in seconds) the participant keeps his hand in the water the maximum he could tolerate.
|
60 minutes
|
|
Change in Cold Pressor Test 10 degree Celsius - pain
Time Frame: 60 minutes
|
Participant puts his right hand in an ice cold water (10 degrees Celsius).
Measure consists of the response to a numeric pain scale (0 to 10) to the pain sensation when the participant withdraw his hand from the water.
|
60 minutes
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Wolnei Caumo, MD. PhD, Federal University of Rio Grande do Sul
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Jensen MP, Sherlin LH, Fregni F, Gianas A, Howe JD, Hakimian S. Baseline brain activity predicts response to neuromodulatory pain treatment. Pain Med. 2014 Dec;15(12):2055-63. doi: 10.1111/pme.12546. Epub 2014 Oct 7.
- Jensen MP, Day MA, Miro J. Neuromodulatory treatments for chronic pain: efficacy and mechanisms. Nat Rev Neurol. 2014 Mar;10(3):167-78. doi: 10.1038/nrneurol.2014.12. Epub 2014 Feb 18.
- Vanegas H, Schaible HG. Descending control of persistent pain: inhibitory or facilitatory? Brain Res Brain Res Rev. 2004 Nov;46(3):295-309. doi: 10.1016/j.brainresrev.2004.07.004.
- Foerster AS, Rezaee Z, Paulus W, Nitsche MA, Dutta A. Effects of Cathode Location and the Size of Anode on Anodal Transcranial Direct Current Stimulation Over the Leg Motor Area in Healthy Humans. Front Neurosci. 2018 Jul 4;12:443. doi: 10.3389/fnins.2018.00443. eCollection 2018.
- Fregni F, Boggio PS, Mansur CG, Wagner T, Ferreira MJ, Lima MC, Rigonatti SP, Marcolin MA, Freedman SD, Nitsche MA, Pascual-Leone A. Transcranial direct current stimulation of the unaffected hemisphere in stroke patients. Neuroreport. 2005 Sep 28;16(14):1551-5. doi: 10.1097/01.wnr.0000177010.44602.5e.
- Beltran Serrano G, Pooch Rodrigues L, Schein B, Zortea M, Torres ILS, Fregni F, Caumo W. The Hypnotic Analgesia Suggestion Mitigated the Effect of the Transcranial Direct Current Stimulation on the Descending Pain Modulatory System: A Proof of Concept Study. J Pain Res. 2020 Sep 16;13:2297-2311. doi: 10.2147/JPR.S253747. eCollection 2020.
- Beltran Serrano G, Rodrigues LP, Schein B, Souza A, Torres ILS, da Conceicao Antunes L, Fregni F, Caumo W. Comparison of Hypnotic Suggestion and Transcranial Direct-Current Stimulation Effects on Pain Perception and the Descending Pain Modulating System: A Crossover Randomized Clinical Trial. Front Neurosci. 2019 Jun 26;13:662. doi: 10.3389/fnins.2019.00662. eCollection 2019.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 18, 2017
Primary Completion (Actual)
November 1, 2018
Study Completion (Actual)
November 1, 2018
Study Registration Dates
First Submitted
September 21, 2017
First Submitted That Met QC Criteria
November 14, 2018
First Posted (Actual)
November 19, 2018
Study Record Updates
Last Update Posted (Actual)
November 26, 2018
Last Update Submitted That Met QC Criteria
November 22, 2018
Last Verified
November 1, 2018
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 16-0635
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pain Acute
-
Rajavithi HospitalCompletedTotal Abdominal Hysterectomy ,Pain , Acute Postoperative,Gabapentin , CelecoxibThailand
-
Umraniye Education and Research HospitalNot yet recruiting
-
Zagazig UniversityRecruiting
-
Ain Shams UniversityNot yet recruiting
-
Ain Shams UniversityNot yet recruitingPostoperative Pain, AcuteEgypt
-
Aga Khan UniversityRecruiting
-
Seoul National University HospitalCompletedPostoperative Pain, AcuteKorea, Republic of
-
Huazhong University of Science and TechnologyCompletedPostoperative Pain, Acute
-
Schulthess KlinikNot yet recruiting
-
Seoul National University HospitalNot yet recruiting
Clinical Trials on Hypnotic analgesia
-
Hospital de Clinicas de Porto AlegreRecruitingFibromyalgia | Hypnosis | Transcranial Direct Current StimulationBrazil
-
Beijing Tiantan HospitalNot yet recruitingCraniotomy | Neurosurgical PatientsChina
-
Centre Hospitalier Universitaire DijonTerminatedPatient With Bronchial EndoscopyFrance
-
Università degli Studi del Piemonte Orientale Amedeo...Azienda Sanitaria Locale BiellaRecruitingPain | Anxiety | Psychological DistressItaly
-
Centre Leon BerardNot yet recruitingStereotactic Body Radiation Therapy | Lung Lesions
-
Fondazione del Piemonte per l'OncologiaCompleted
-
Hypnalgesics, LLCBoston Medical Center; Ohio State University; Tufts Medical CenterCompletedClaustrophobia | Complication of Diagnostic ProcedureUnited States
-
Hypnalgesics, LLCDuke University; Ohio State UniversityCompletedClaustrophobia | Complication of Diagnostic ProcedureUnited States
-
Centre Hospitalier de MontaubanRecruiting
-
National Jewish HealthCompletedHypnotic Dependence Among Those With InsomniaUnited States